The dynamics of drug launch has been an under-researched area. Most of the studies in this field focus on developed countries, quite uniform in terms of disease profile and regulatory framework, and analyse whether stringency in regulation influences launch delay. Developing countries, in...

The dynamics of drug launch has been an under-researched area, especially in the context of developing countries, which have diverse disease profiles and weaker forms of regulation compared to developed countries. A limited set of studies, undertaken in recent years, on the diffusion of new...

Die Nutzung des in öffentlichen Forschungseinrichtungen vorhandenen Wissens kann für Innovationsprozesse privater Unternehmen von wesentlicher Bedeutung sein. Kooperationsbeziehungen zwischen Unternehmen und Forschungseinrichtungen stellen ein wesentliches Medium zum Transfer dieses Wissens...